nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—IMPDH1—Mycophenolic acid—psoriasis	0.478	0.642	CbGbCtD
Ribavirin—IMPDH1—Mycophenolate mofetil—psoriasis	0.267	0.358	CbGbCtD
Ribavirin—Glucosamine—IFNG—psoriasis	0.00217	0.705	CrCbGaD
Ribavirin—NT5C2—Purine catabolism—CAT—psoriasis	0.00118	0.228	CbGpPWpGaD
Ribavirin—Glucosamine—TNF—psoriasis	0.00091	0.295	CrCbGaD
Ribavirin—ENPP1—Endochondral Ossification—RUNX3—psoriasis	0.00051	0.0989	CbGpPWpGaD
Ribavirin—ENPP1—Dexamethasone—Clobetasol propionate—psoriasis	0.000476	0.0968	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Clobetasol propionate—psoriasis	0.000476	0.0968	CbGdCrCtD
Ribavirin—NT5C2—Purine metabolism—CAT—psoriasis	0.000453	0.0878	CbGpPWpGaD
Ribavirin—ENPP1—Betamethasone—Fluocinonide—psoriasis	0.000381	0.0775	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Beclomethasone—psoriasis	0.000381	0.0775	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Beclomethasone—psoriasis	0.000381	0.0775	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Fluocinonide—psoriasis	0.000381	0.0775	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00037	0.0754	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00037	0.0754	CbGdCrCtD
Ribavirin—IMPDH1—Purine metabolism—CAT—psoriasis	0.00037	0.0716	CbGpPWpGaD
Ribavirin—ADK—Purine metabolism—CAT—psoriasis	0.000344	0.0666	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—CAT—psoriasis	0.000228	0.0441	CbGpPWpGaD
Ribavirin—ENPP1—Dexamethasone—Hydrocortisone—psoriasis	0.000187	0.0381	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Hydrocortisone—psoriasis	0.000187	0.0381	CbGdCrCtD
Ribavirin—IMPDH1—Nucleotide metabolism—CAT—psoriasis	0.000186	0.036	CbGpPWpGaD
Ribavirin—ENPP1—Dexamethasone—Betamethasone—psoriasis	0.000174	0.0353	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Dexamethasone—psoriasis	0.000174	0.0353	CbGdCrCtD
Ribavirin—ADK—Nucleotide metabolism—CAT—psoriasis	0.000173	0.0334	CbGpPWpGaD
Ribavirin—ENPP1—Dexamethasone—Triamcinolone—psoriasis	0.00017	0.0345	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Triamcinolone—psoriasis	0.00017	0.0345	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Prednisone—psoriasis	0.000161	0.0328	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Prednisone—psoriasis	0.000161	0.0328	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Prednisolone—psoriasis	0.000157	0.032	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Prednisolone—psoriasis	0.000157	0.032	CbGdCrCtD
Ribavirin—ENPP1—Insulin Signaling—SOCS1—psoriasis	0.000135	0.0262	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000112	0.0218	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—VEGFA—psoriasis	0.000112	0.0217	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—CP—psoriasis	8.37e-05	0.0162	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—psoriasis	8.12e-05	0.0157	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NDUFA5—psoriasis	8.1e-05	0.0157	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NDUFA5—psoriasis	8.1e-05	0.0157	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP2S1—psoriasis	6.89e-05	0.0133	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP2S1—psoriasis	6.89e-05	0.0133	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NDUFA5—psoriasis	6.61e-05	0.0128	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—JUN—psoriasis	6.16e-05	0.0119	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NDUFA5—psoriasis	6.14e-05	0.0119	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CP—psoriasis	5.71e-05	0.0111	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CYP2S1—psoriasis	5.62e-05	0.0109	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CARM1—psoriasis	5.44e-05	0.0105	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYP2S1—psoriasis	5.22e-05	0.0101	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CP—psoriasis	4.26e-05	0.00824	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.06e-05	0.00786	CbGpPWpGaD
Ribavirin—Dyspepsia—Hydrocortisone—psoriasis	3.79e-05	0.000157	CcSEcCtD
Ribavirin—Haemoglobin—Methotrexate—psoriasis	3.79e-05	0.000157	CcSEcCtD
Ribavirin—Rash—Mycophenolic acid—psoriasis	3.77e-05	0.000156	CcSEcCtD
Ribavirin—Dermatitis—Mycophenolic acid—psoriasis	3.77e-05	0.000156	CcSEcCtD
Ribavirin—Pain—Prednisolone—psoriasis	3.77e-05	0.000156	CcSEcCtD
Ribavirin—Haemorrhage—Methotrexate—psoriasis	3.77e-05	0.000156	CcSEcCtD
Ribavirin—Hepatitis—Methotrexate—psoriasis	3.77e-05	0.000156	CcSEcCtD
Ribavirin—Urticaria—Mycophenolate mofetil—psoriasis	3.75e-05	0.000155	CcSEcCtD
Ribavirin—Headache—Mycophenolic acid—psoriasis	3.75e-05	0.000155	CcSEcCtD
Ribavirin—Decreased appetite—Hydrocortisone—psoriasis	3.74e-05	0.000155	CcSEcCtD
Ribavirin—Pharyngitis—Methotrexate—psoriasis	3.74e-05	0.000155	CcSEcCtD
Ribavirin—Abdominal pain—Mycophenolate mofetil—psoriasis	3.73e-05	0.000155	CcSEcCtD
Ribavirin—Body temperature increased—Mycophenolate mofetil—psoriasis	3.73e-05	0.000155	CcSEcCtD
Ribavirin—Urinary tract disorder—Methotrexate—psoriasis	3.72e-05	0.000154	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.72e-05	0.000154	CcSEcCtD
Ribavirin—Fatigue—Hydrocortisone—psoriasis	3.71e-05	0.000154	CcSEcCtD
Ribavirin—Vision blurred—Prednisone—psoriasis	3.7e-05	0.000153	CcSEcCtD
Ribavirin—Urethral disorder—Methotrexate—psoriasis	3.69e-05	0.000153	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.69e-05	0.000153	CcSEcCtD
Ribavirin—Pain—Hydrocortisone—psoriasis	3.68e-05	0.000152	CcSEcCtD
Ribavirin—Oedema—Betamethasone—psoriasis	3.68e-05	0.000152	CcSEcCtD
Ribavirin—Anaphylactic shock—Betamethasone—psoriasis	3.68e-05	0.000152	CcSEcCtD
Ribavirin—Anaphylactic shock—Dexamethasone—psoriasis	3.68e-05	0.000152	CcSEcCtD
Ribavirin—Oedema—Dexamethasone—psoriasis	3.68e-05	0.000152	CcSEcCtD
Ribavirin—Insomnia—Triamcinolone—psoriasis	3.67e-05	0.000152	CcSEcCtD
Ribavirin—Ill-defined disorder—Prednisone—psoriasis	3.64e-05	0.000151	CcSEcCtD
Ribavirin—Paraesthesia—Triamcinolone—psoriasis	3.64e-05	0.000151	CcSEcCtD
Ribavirin—Feeling abnormal—Prednisolone—psoriasis	3.63e-05	0.00015	CcSEcCtD
Ribavirin—Visual impairment—Methotrexate—psoriasis	3.63e-05	0.00015	CcSEcCtD
Ribavirin—Anaemia—Prednisone—psoriasis	3.63e-05	0.00015	CcSEcCtD
Ribavirin—Shock—Dexamethasone—psoriasis	3.62e-05	0.00015	CcSEcCtD
Ribavirin—Shock—Betamethasone—psoriasis	3.62e-05	0.00015	CcSEcCtD
Ribavirin—Dyspnoea—Triamcinolone—psoriasis	3.61e-05	0.00015	CcSEcCtD
Ribavirin—Nervous system disorder—Betamethasone—psoriasis	3.61e-05	0.000149	CcSEcCtD
Ribavirin—Nervous system disorder—Dexamethasone—psoriasis	3.61e-05	0.000149	CcSEcCtD
Ribavirin—Agitation—Prednisone—psoriasis	3.61e-05	0.000149	CcSEcCtD
Ribavirin—Thrombocytopenia—Dexamethasone—psoriasis	3.6e-05	0.000149	CcSEcCtD
Ribavirin—Thrombocytopenia—Betamethasone—psoriasis	3.6e-05	0.000149	CcSEcCtD
Ribavirin—Tachycardia—Dexamethasone—psoriasis	3.59e-05	0.000149	CcSEcCtD
Ribavirin—Tachycardia—Betamethasone—psoriasis	3.59e-05	0.000149	CcSEcCtD
Ribavirin—Angioedema—Prednisone—psoriasis	3.59e-05	0.000148	CcSEcCtD
Ribavirin—Hypersensitivity—Cyclosporine—psoriasis	3.57e-05	0.000148	CcSEcCtD
Ribavirin—Dyspepsia—Triamcinolone—psoriasis	3.57e-05	0.000148	CcSEcCtD
Ribavirin—Erythema multiforme—Methotrexate—psoriasis	3.56e-05	0.000147	CcSEcCtD
Ribavirin—Nausea—Mycophenolic acid—psoriasis	3.56e-05	0.000147	CcSEcCtD
Ribavirin—Hyperhidrosis—Dexamethasone—psoriasis	3.55e-05	0.000147	CcSEcCtD
Ribavirin—Hyperhidrosis—Betamethasone—psoriasis	3.55e-05	0.000147	CcSEcCtD
Ribavirin—Feeling abnormal—Hydrocortisone—psoriasis	3.55e-05	0.000147	CcSEcCtD
Ribavirin—Malaise—Prednisone—psoriasis	3.54e-05	0.000146	CcSEcCtD
Ribavirin—Vertigo—Prednisone—psoriasis	3.53e-05	0.000146	CcSEcCtD
Ribavirin—Eye disorder—Methotrexate—psoriasis	3.52e-05	0.000146	CcSEcCtD
Ribavirin—Gastrointestinal pain—Hydrocortisone—psoriasis	3.52e-05	0.000146	CcSEcCtD
Ribavirin—Syncope—Prednisone—psoriasis	3.52e-05	0.000146	CcSEcCtD
Ribavirin—Tinnitus—Methotrexate—psoriasis	3.51e-05	0.000145	CcSEcCtD
Ribavirin—Anorexia—Betamethasone—psoriasis	3.51e-05	0.000145	CcSEcCtD
Ribavirin—Anorexia—Dexamethasone—psoriasis	3.51e-05	0.000145	CcSEcCtD
Ribavirin—Urticaria—Prednisolone—psoriasis	3.5e-05	0.000145	CcSEcCtD
Ribavirin—Cardiac disorder—Methotrexate—psoriasis	3.5e-05	0.000145	CcSEcCtD
Ribavirin—Fatigue—Triamcinolone—psoriasis	3.49e-05	0.000145	CcSEcCtD
Ribavirin—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.48e-05	0.000144	CcSEcCtD
Ribavirin—Asthenia—Cyclosporine—psoriasis	3.47e-05	0.000144	CcSEcCtD
Ribavirin—Pain—Triamcinolone—psoriasis	3.47e-05	0.000143	CcSEcCtD
Ribavirin—Loss of consciousness—Prednisone—psoriasis	3.45e-05	0.000143	CcSEcCtD
Ribavirin—Hypotension—Betamethasone—psoriasis	3.44e-05	0.000142	CcSEcCtD
Ribavirin—Hypotension—Dexamethasone—psoriasis	3.44e-05	0.000142	CcSEcCtD
Ribavirin—Pruritus—Cyclosporine—psoriasis	3.43e-05	0.000142	CcSEcCtD
Ribavirin—Urticaria—Hydrocortisone—psoriasis	3.42e-05	0.000141	CcSEcCtD
Ribavirin—Angiopathy—Methotrexate—psoriasis	3.42e-05	0.000141	CcSEcCtD
Ribavirin—Immune system disorder—Methotrexate—psoriasis	3.4e-05	0.000141	CcSEcCtD
Ribavirin—Body temperature increased—Hydrocortisone—psoriasis	3.4e-05	0.000141	CcSEcCtD
Ribavirin—Abdominal pain—Hydrocortisone—psoriasis	3.4e-05	0.000141	CcSEcCtD
Ribavirin—Convulsion—Prednisone—psoriasis	3.4e-05	0.000141	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—psoriasis	3.4e-05	0.00014	CcSEcCtD
Ribavirin—Asthenia—Mycophenolate mofetil—psoriasis	3.39e-05	0.00014	CcSEcCtD
Ribavirin—Hypertension—Prednisone—psoriasis	3.39e-05	0.00014	CcSEcCtD
Ribavirin—Chills—Methotrexate—psoriasis	3.38e-05	0.00014	CcSEcCtD
Ribavirin—ENPP1—Metabolism—CARM1—psoriasis	3.36e-05	0.00652	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CARM1—psoriasis	3.36e-05	0.00652	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Betamethasone—psoriasis	3.35e-05	0.000139	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.35e-05	0.000139	CcSEcCtD
Ribavirin—Pruritus—Mycophenolate mofetil—psoriasis	3.34e-05	0.000138	CcSEcCtD
Ribavirin—Myalgia—Prednisone—psoriasis	3.34e-05	0.000138	CcSEcCtD
Ribavirin—Arthralgia—Prednisone—psoriasis	3.34e-05	0.000138	CcSEcCtD
Ribavirin—Feeling abnormal—Triamcinolone—psoriasis	3.34e-05	0.000138	CcSEcCtD
Ribavirin—Anxiety—Prednisone—psoriasis	3.33e-05	0.000138	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—psoriasis	3.33e-05	0.000138	CcSEcCtD
Ribavirin—Insomnia—Betamethasone—psoriasis	3.33e-05	0.000138	CcSEcCtD
Ribavirin—Insomnia—Dexamethasone—psoriasis	3.33e-05	0.000138	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.32e-05	0.000137	CcSEcCtD
Ribavirin—Diarrhoea—Cyclosporine—psoriasis	3.31e-05	0.000137	CcSEcCtD
Ribavirin—Paraesthesia—Dexamethasone—psoriasis	3.3e-05	0.000137	CcSEcCtD
Ribavirin—Paraesthesia—Betamethasone—psoriasis	3.3e-05	0.000137	CcSEcCtD
Ribavirin—Discomfort—Prednisone—psoriasis	3.3e-05	0.000137	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—psoriasis	3.3e-05	0.000137	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—psoriasis	3.28e-05	0.000136	CcSEcCtD
Ribavirin—Erythema—Methotrexate—psoriasis	3.28e-05	0.000136	CcSEcCtD
Ribavirin—Hypersensitivity—Prednisolone—psoriasis	3.25e-05	0.000134	CcSEcCtD
Ribavirin—Dyspepsia—Betamethasone—psoriasis	3.24e-05	0.000134	CcSEcCtD
Ribavirin—Dyspepsia—Dexamethasone—psoriasis	3.24e-05	0.000134	CcSEcCtD
Ribavirin—Diarrhoea—Mycophenolate mofetil—psoriasis	3.23e-05	0.000134	CcSEcCtD
Ribavirin—Urticaria—Triamcinolone—psoriasis	3.22e-05	0.000133	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—psoriasis	3.21e-05	0.000133	CcSEcCtD
Ribavirin—Body temperature increased—Triamcinolone—psoriasis	3.2e-05	0.000133	CcSEcCtD
Ribavirin—Dizziness—Cyclosporine—psoriasis	3.2e-05	0.000133	CcSEcCtD
Ribavirin—Oedema—Prednisone—psoriasis	3.2e-05	0.000133	CcSEcCtD
Ribavirin—Anaphylactic shock—Prednisone—psoriasis	3.2e-05	0.000133	CcSEcCtD
Ribavirin—Decreased appetite—Dexamethasone—psoriasis	3.2e-05	0.000132	CcSEcCtD
Ribavirin—Decreased appetite—Betamethasone—psoriasis	3.2e-05	0.000132	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Betamethasone—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Dexamethasone—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Back pain—Methotrexate—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Hypersensitivity—Hydrocortisone—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Fatigue—Betamethasone—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Fatigue—Dexamethasone—psoriasis	3.17e-05	0.000131	CcSEcCtD
Ribavirin—Shock—Prednisone—psoriasis	3.15e-05	0.00013	CcSEcCtD
Ribavirin—Pain—Dexamethasone—psoriasis	3.14e-05	0.00013	CcSEcCtD
Ribavirin—Pain—Betamethasone—psoriasis	3.14e-05	0.00013	CcSEcCtD
Ribavirin—Nervous system disorder—Prednisone—psoriasis	3.14e-05	0.00013	CcSEcCtD
Ribavirin—Tachycardia—Prednisone—psoriasis	3.13e-05	0.000129	CcSEcCtD
Ribavirin—Dizziness—Mycophenolate mofetil—psoriasis	3.12e-05	0.000129	CcSEcCtD
Ribavirin—Skin disorder—Prednisone—psoriasis	3.11e-05	0.000129	CcSEcCtD
Ribavirin—Hyperhidrosis—Prednisone—psoriasis	3.1e-05	0.000128	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—psoriasis	3.09e-05	0.000128	CcSEcCtD
Ribavirin—Asthenia—Hydrocortisone—psoriasis	3.09e-05	0.000128	CcSEcCtD
Ribavirin—Vomiting—Cyclosporine—psoriasis	3.08e-05	0.000127	CcSEcCtD
Ribavirin—Rash—Cyclosporine—psoriasis	3.05e-05	0.000126	CcSEcCtD
Ribavirin—Anorexia—Prednisone—psoriasis	3.05e-05	0.000126	CcSEcCtD
Ribavirin—Dermatitis—Cyclosporine—psoriasis	3.05e-05	0.000126	CcSEcCtD
Ribavirin—Pruritus—Hydrocortisone—psoriasis	3.05e-05	0.000126	CcSEcCtD
Ribavirin—Ill-defined disorder—Methotrexate—psoriasis	3.04e-05	0.000126	CcSEcCtD
Ribavirin—Headache—Cyclosporine—psoriasis	3.03e-05	0.000126	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—psoriasis	3.03e-05	0.000125	CcSEcCtD
Ribavirin—Feeling abnormal—Dexamethasone—psoriasis	3.03e-05	0.000125	CcSEcCtD
Ribavirin—Feeling abnormal—Betamethasone—psoriasis	3.03e-05	0.000125	CcSEcCtD
Ribavirin—Gastrointestinal pain—Betamethasone—psoriasis	3.01e-05	0.000124	CcSEcCtD
Ribavirin—Gastrointestinal pain—Dexamethasone—psoriasis	3.01e-05	0.000124	CcSEcCtD
Ribavirin—Vomiting—Mycophenolate mofetil—psoriasis	3e-05	0.000124	CcSEcCtD
Ribavirin—Hypersensitivity—Triamcinolone—psoriasis	2.99e-05	0.000124	CcSEcCtD
Ribavirin—Rash—Mycophenolate mofetil—psoriasis	2.98e-05	0.000123	CcSEcCtD
Ribavirin—Dermatitis—Mycophenolate mofetil—psoriasis	2.98e-05	0.000123	CcSEcCtD
Ribavirin—Headache—Mycophenolate mofetil—psoriasis	2.96e-05	0.000122	CcSEcCtD
Ribavirin—Malaise—Methotrexate—psoriasis	2.96e-05	0.000122	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—psoriasis	2.95e-05	0.000122	CcSEcCtD
Ribavirin—Diarrhoea—Hydrocortisone—psoriasis	2.94e-05	0.000122	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—psoriasis	2.94e-05	0.000121	CcSEcCtD
Ribavirin—Urticaria—Dexamethasone—psoriasis	2.92e-05	0.000121	CcSEcCtD
Ribavirin—Urticaria—Betamethasone—psoriasis	2.92e-05	0.000121	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Prednisone—psoriasis	2.92e-05	0.000121	CcSEcCtD
Ribavirin—Dizziness—Prednisolone—psoriasis	2.91e-05	0.000121	CcSEcCtD
Ribavirin—Asthenia—Triamcinolone—psoriasis	2.91e-05	0.00012	CcSEcCtD
Ribavirin—Body temperature increased—Betamethasone—psoriasis	2.91e-05	0.00012	CcSEcCtD
Ribavirin—Abdominal pain—Dexamethasone—psoriasis	2.91e-05	0.00012	CcSEcCtD
Ribavirin—Abdominal pain—Betamethasone—psoriasis	2.91e-05	0.00012	CcSEcCtD
Ribavirin—Body temperature increased—Dexamethasone—psoriasis	2.91e-05	0.00012	CcSEcCtD
Ribavirin—Insomnia—Prednisone—psoriasis	2.9e-05	0.00012	CcSEcCtD
Ribavirin—Nausea—Cyclosporine—psoriasis	2.88e-05	0.000119	CcSEcCtD
Ribavirin—Paraesthesia—Prednisone—psoriasis	2.88e-05	0.000119	CcSEcCtD
Ribavirin—Pruritus—Triamcinolone—psoriasis	2.87e-05	0.000119	CcSEcCtD
Ribavirin—Cough—Methotrexate—psoriasis	2.86e-05	0.000118	CcSEcCtD
Ribavirin—Dizziness—Hydrocortisone—psoriasis	2.85e-05	0.000118	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—psoriasis	2.84e-05	0.000118	CcSEcCtD
Ribavirin—Dyspepsia—Prednisone—psoriasis	2.82e-05	0.000117	CcSEcCtD
Ribavirin—Nausea—Mycophenolate mofetil—psoriasis	2.81e-05	0.000116	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—psoriasis	2.79e-05	0.000116	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—psoriasis	2.79e-05	0.000116	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—psoriasis	2.79e-05	0.000116	CcSEcCtD
Ribavirin—Decreased appetite—Prednisone—psoriasis	2.78e-05	0.000115	CcSEcCtD
Ribavirin—Rash—Prednisolone—psoriasis	2.78e-05	0.000115	CcSEcCtD
Ribavirin—Dermatitis—Prednisolone—psoriasis	2.78e-05	0.000115	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.77e-05	0.000115	CcSEcCtD
Ribavirin—Fatigue—Prednisone—psoriasis	2.76e-05	0.000114	CcSEcCtD
Ribavirin—Headache—Prednisolone—psoriasis	2.76e-05	0.000114	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—psoriasis	2.76e-05	0.000114	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CARM1—psoriasis	2.74e-05	0.00531	CbGpPWpGaD
Ribavirin—Constipation—Prednisone—psoriasis	2.74e-05	0.000113	CcSEcCtD
Ribavirin—Vomiting—Hydrocortisone—psoriasis	2.74e-05	0.000113	CcSEcCtD
Ribavirin—Rash—Hydrocortisone—psoriasis	2.71e-05	0.000112	CcSEcCtD
Ribavirin—Dermatitis—Hydrocortisone—psoriasis	2.71e-05	0.000112	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—psoriasis	2.7e-05	0.000112	CcSEcCtD
Ribavirin—Headache—Hydrocortisone—psoriasis	2.7e-05	0.000112	CcSEcCtD
Ribavirin—Dizziness—Triamcinolone—psoriasis	2.68e-05	0.000111	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—psoriasis	2.68e-05	0.000111	CcSEcCtD
Ribavirin—Feeling abnormal—Prednisone—psoriasis	2.64e-05	0.000109	CcSEcCtD
Ribavirin—Asthenia—Dexamethasone—psoriasis	2.64e-05	0.000109	CcSEcCtD
Ribavirin—Asthenia—Betamethasone—psoriasis	2.64e-05	0.000109	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—psoriasis	2.62e-05	0.000109	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—psoriasis	2.62e-05	0.000108	CcSEcCtD
Ribavirin—Gastrointestinal pain—Prednisone—psoriasis	2.62e-05	0.000108	CcSEcCtD
Ribavirin—Nausea—Prednisolone—psoriasis	2.62e-05	0.000108	CcSEcCtD
Ribavirin—Pruritus—Betamethasone—psoriasis	2.6e-05	0.000108	CcSEcCtD
Ribavirin—Pruritus—Dexamethasone—psoriasis	2.6e-05	0.000108	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—psoriasis	2.6e-05	0.000108	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—psoriasis	2.59e-05	0.000107	CcSEcCtD
Ribavirin—Vomiting—Triamcinolone—psoriasis	2.58e-05	0.000107	CcSEcCtD
Ribavirin—Nausea—Hydrocortisone—psoriasis	2.56e-05	0.000106	CcSEcCtD
Ribavirin—Rash—Triamcinolone—psoriasis	2.56e-05	0.000106	CcSEcCtD
Ribavirin—Dermatitis—Triamcinolone—psoriasis	2.55e-05	0.000106	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—psoriasis	2.55e-05	0.000106	CcSEcCtD
Ribavirin—ADK—Metabolism—CARM1—psoriasis	2.55e-05	0.00494	CbGpPWpGaD
Ribavirin—Urticaria—Prednisone—psoriasis	2.54e-05	0.000105	CcSEcCtD
Ribavirin—Headache—Triamcinolone—psoriasis	2.54e-05	0.000105	CcSEcCtD
Ribavirin—Abdominal pain—Prednisone—psoriasis	2.53e-05	0.000105	CcSEcCtD
Ribavirin—Body temperature increased—Prednisone—psoriasis	2.53e-05	0.000105	CcSEcCtD
Ribavirin—Diarrhoea—Dexamethasone—psoriasis	2.52e-05	0.000104	CcSEcCtD
Ribavirin—Diarrhoea—Betamethasone—psoriasis	2.52e-05	0.000104	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—psoriasis	2.5e-05	0.000103	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—psoriasis	2.44e-05	0.000101	CcSEcCtD
Ribavirin—Dizziness—Dexamethasone—psoriasis	2.43e-05	0.000101	CcSEcCtD
Ribavirin—Dizziness—Betamethasone—psoriasis	2.43e-05	0.000101	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—psoriasis	2.42e-05	0.0001	CcSEcCtD
Ribavirin—Nausea—Triamcinolone—psoriasis	2.41e-05	9.96e-05	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—psoriasis	2.4e-05	9.94e-05	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—psoriasis	2.39e-05	9.87e-05	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—psoriasis	2.38e-05	9.85e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Prednisone—psoriasis	2.36e-05	9.76e-05	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—psoriasis	2.36e-05	9.75e-05	CcSEcCtD
Ribavirin—Vomiting—Betamethasone—psoriasis	2.34e-05	9.67e-05	CcSEcCtD
Ribavirin—Vomiting—Dexamethasone—psoriasis	2.34e-05	9.67e-05	CcSEcCtD
Ribavirin—Decreased appetite—Methotrexate—psoriasis	2.33e-05	9.63e-05	CcSEcCtD
Ribavirin—Rash—Dexamethasone—psoriasis	2.32e-05	9.59e-05	CcSEcCtD
Ribavirin—Rash—Betamethasone—psoriasis	2.32e-05	9.59e-05	CcSEcCtD
Ribavirin—Dermatitis—Betamethasone—psoriasis	2.32e-05	9.59e-05	CcSEcCtD
Ribavirin—Dermatitis—Dexamethasone—psoriasis	2.32e-05	9.59e-05	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—psoriasis	2.31e-05	9.56e-05	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—psoriasis	2.31e-05	9.55e-05	CcSEcCtD
Ribavirin—Headache—Dexamethasone—psoriasis	2.3e-05	9.53e-05	CcSEcCtD
Ribavirin—Headache—Betamethasone—psoriasis	2.3e-05	9.53e-05	CcSEcCtD
Ribavirin—Asthenia—Prednisone—psoriasis	2.3e-05	9.51e-05	CcSEcCtD
Ribavirin—Pain—Methotrexate—psoriasis	2.29e-05	9.47e-05	CcSEcCtD
Ribavirin—Pruritus—Prednisone—psoriasis	2.27e-05	9.38e-05	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—psoriasis	2.21e-05	9.13e-05	CcSEcCtD
Ribavirin—Diarrhoea—Prednisone—psoriasis	2.19e-05	9.07e-05	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—psoriasis	2.19e-05	9.06e-05	CcSEcCtD
Ribavirin—Nausea—Dexamethasone—psoriasis	2.18e-05	9.04e-05	CcSEcCtD
Ribavirin—Nausea—Betamethasone—psoriasis	2.18e-05	9.04e-05	CcSEcCtD
Ribavirin—Urticaria—Methotrexate—psoriasis	2.13e-05	8.8e-05	CcSEcCtD
Ribavirin—Dizziness—Prednisone—psoriasis	2.12e-05	8.76e-05	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—psoriasis	2.12e-05	8.75e-05	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—psoriasis	2.12e-05	8.75e-05	CcSEcCtD
Ribavirin—NT5C2—Metabolism—CAT—psoriasis	2.07e-05	0.00401	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CAT—psoriasis	2.07e-05	0.00401	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HLA-A—psoriasis	2.06e-05	0.00398	CbGpPWpGaD
Ribavirin—Vomiting—Prednisone—psoriasis	2.04e-05	8.43e-05	CcSEcCtD
Ribavirin—Rash—Prednisone—psoriasis	2.02e-05	8.36e-05	CcSEcCtD
Ribavirin—Dermatitis—Prednisone—psoriasis	2.02e-05	8.35e-05	CcSEcCtD
Ribavirin—Headache—Prednisone—psoriasis	2.01e-05	8.3e-05	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—psoriasis	1.97e-05	8.16e-05	CcSEcCtD
Ribavirin—ENPP1—Disease—APOE—psoriasis	1.92e-05	0.00372	CbGpPWpGaD
Ribavirin—Asthenia—Methotrexate—psoriasis	1.92e-05	7.95e-05	CcSEcCtD
Ribavirin—Nausea—Prednisone—psoriasis	1.9e-05	7.87e-05	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—psoriasis	1.89e-05	7.84e-05	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—psoriasis	1.83e-05	7.58e-05	CcSEcCtD
Ribavirin—ENPP1—Disease—NOS2—psoriasis	1.79e-05	0.00347	CbGpPWpGaD
Ribavirin—Dizziness—Methotrexate—psoriasis	1.77e-05	7.32e-05	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—psoriasis	1.7e-05	7.04e-05	CcSEcCtD
Ribavirin—Rash—Methotrexate—psoriasis	1.69e-05	6.98e-05	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CAT—psoriasis	1.69e-05	0.00327	CbGpPWpGaD
Ribavirin—Dermatitis—Methotrexate—psoriasis	1.69e-05	6.98e-05	CcSEcCtD
Ribavirin—Headache—Methotrexate—psoriasis	1.68e-05	6.94e-05	CcSEcCtD
Ribavirin—NT5C2—Metabolism—APOE—psoriasis	1.61e-05	0.00312	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—APOE—psoriasis	1.61e-05	0.00312	CbGpPWpGaD
Ribavirin—Nausea—Methotrexate—psoriasis	1.59e-05	6.58e-05	CcSEcCtD
Ribavirin—ADK—Metabolism—CAT—psoriasis	1.57e-05	0.00304	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TYK2—psoriasis	1.47e-05	0.00284	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PPARG—psoriasis	1.4e-05	0.00271	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PPARG—psoriasis	1.4e-05	0.00271	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CD4—psoriasis	1.33e-05	0.00257	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—APOE—psoriasis	1.31e-05	0.00254	CbGpPWpGaD
Ribavirin—ADK—Metabolism—APOE—psoriasis	1.22e-05	0.00236	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PPARG—psoriasis	1.14e-05	0.00221	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PPARG—psoriasis	1.06e-05	0.00206	CbGpPWpGaD
Ribavirin—ENPP1—Disease—STAT3—psoriasis	1.03e-05	0.00199	CbGpPWpGaD
Ribavirin—ENPP1—Disease—IL6—psoriasis	7.17e-06	0.00139	CbGpPWpGaD
